Differences in pandemic influenza vaccination policies for pregnant women in Europe
<p>Abstract</p> <p>Background</p> <p>An important component of the policy to deal with the H1N1 pandemic in 2009 was to develop and implement vaccination. Since pregnant women were found to be at particular risk of severe morbidity and mortality, the World Health Organi...
Main Authors: | Marnoch Gordon J, Dolk Helen, Luteijn Johannes M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | BMC Public Health |
Online Access: | http://www.biomedcentral.com/1471-2458/11/819 |
Similar Items
-
2009 H1N1 pandemic influenza in Europe: congenital anomaly surveillance response
by: Luteijn, Johannes Michiel
Published: (2013) -
Pandemic Influenza and Pregnant Women
by: Sonja A. Rasmussen, et al.
Published: (2008-01-01) -
Determinants of influenza vaccine hesitancy among pregnant women in Europe: a systematic review
by: Gbadebo Collins Adeyanju, et al.
Published: (2021-09-01) -
IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
by: M. P. Kostinov, et al.
Published: (2017-06-01) -
Immunogenicity and safety of subunit influenza vaccines in pregnant women
by: Mikhail P. Kostinov, et al.
Published: (2018-04-01)